KISS1 and neoplasm: In this study, we found that AR treatment increased the levels of the plasma neuropeptide hormone, kisspeptin, and the expression levels of its receptor, Gpr54, in the hypothalamus, T cells, and tumor‐infiltrating T cells, suggesting a correlation between the neuroendocrine system and tumor microenvironment.